You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,310,094


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,310,094
Title: Ready-to-use esmolol solution
Abstract:A ready-to-use injectable, aqueous pharmaceutical composition for the treatment of cardiac conditions, comprising methyl-3-[4-(2-hydroxy-3-isopropylamino) propoxy] phenylpropionate hydrochloride (esmolol hydrochloride), a buffering agent and an osmotic-adjusting agent, as well as a method for its manufacture in a container, is disclosed.
Inventor(s): Liu; Jie (Scotch Plains, NJ), Pejaver; Satish K. (Bridgewater, NJ), Owoo; George (North Plainfield, NJ)
Assignee: Baxter International Inc. (Deerfield, IL)
Application Number:09/759,547
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,310,094
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,310,094

Introduction

United States Patent 6,310,094, hereafter referred to as the '094 Patent, is a significant intellectual property asset that has been the subject of various legal and technical analyses. This article delves into the details of the patent's scope, claims, and the broader patent landscape in which it operates.

Background of the Patent

The '094 Patent, along with its companion patent 6,528,540 ('540 Patent), has been involved in several legal disputes, notably in the case of Baxter Healthcare Corp. v. HQ Specialty Pharma Corp[1][2].

Patent Claims and Construction

Claim Structure

The '094 Patent contains a set of claims that define the scope of the invention. Patent claims are crucial as they delineate what is protected by the patent. The claims in the '094 Patent are structured to include both independent and dependent claims, each contributing to the overall definition of the invention.

Claim Construction

Claim construction is a critical step in determining the scope of a patent. It involves interpreting the language of the claims to understand what is covered by the patent. The court must construe the asserted claim terms, which is a question of law[1].

Key Claim Terms and Interpretation

Osmotic-Adjusting Agent

One of the key terms in the '094 Patent is "osmotic-adjusting agent." The patent specifies that this agent is used to adjust the tonicity of the solution. The claims and the detailed description of the invention explicitly teach that the osmotic-adjusting agent includes substances like sodium chloride, dextrose, sodium bicarbonate, calcium chloride, potassium chloride, sodium lactate, Ringer's solution, and lactated Ringer's solution[1].

Disavowal and Scope

The patent's specification and claims must be carefully analyzed to determine if there is any disavowal of claim scope. In the case of the '094 Patent, the court found that the patentees disavowed any meaning of "osmotic-adjusting agent" beyond an agent to adjust the tonicity of the claimed solution. This interpretation is based on the detailed description and the specific definitions provided in the claims[1].

Patent Scope and Breadth

Metrics for Measuring Patent Scope

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. These metrics help in assessing the breadth and clarity of the patent claims. Research indicates that narrower claims are associated with a higher probability of grant and a shorter examination process[3].

Examination Process Impact

The patent examination process often narrows the scope of patent claims. This is evident from studies showing that the examination process tends to reduce both claim length and claim count, particularly when the examination duration is longer. This narrowing helps in clarifying the patent's scope and reducing potential disputes[3].

Patent Infringement Analysis

Standard for Infringement

A claim for patent infringement arises when an entity without authority makes, uses, or sells any patented invention within the United States during the life of the patent. The analysis involves two steps: claim construction and comparing the construed claims with the accused infringing product[1].

Application to the '094 Patent

In the context of the '094 Patent, any alleged infringement would need to be evaluated against the construed claims. For instance, if a product uses an osmotic-adjusting agent in a manner that falls within the defined scope of the '094 Patent, it could be considered infringing.

Trade Secrets and Confidential Information

Role in Patent Disputes

The '094 Patent case also involves allegations of trade secret misappropriation. One of the inventors, George Owoo, was accused of disclosing confidential information and trade secrets to HQ Specialty Pharma Corp, which assisted in developing a generic product. This highlights the importance of protecting both patent and trade secret rights in maintaining competitive advantage[1].

Patent Landscape and Search Tools

USPTO Resources

The United States Patent and Trademark Office (USPTO) provides several resources for searching and analyzing patents. Tools like the Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) are essential for conducting thorough patent searches and understanding the broader patent landscape[4].

Global Dossier and Common Citation Document

The Global Dossier service allows users to access file histories of related applications from participating IP offices, providing a comprehensive view of the patent family. The Common Citation Document (CCD) consolidates prior art citations from multiple offices, facilitating a more integrated global patent search[4].

Legal and Strategic Implications

Litigation and Licensing

The '094 Patent has been involved in significant litigation, which underscores the importance of robust patent claims and thorough claim construction. Companies must carefully manage their patent portfolios to avoid costly litigation and ensure that their inventions are adequately protected[1][2].

Innovation and Competition

The scope and claims of the '094 Patent influence innovation and competition in the relevant industry. Clear and well-defined claims can encourage innovation by providing a clear understanding of what is protected and what is available for further development[3].

Key Takeaways

  • Claim Construction: The interpretation of claim terms is crucial and must be done carefully to understand the scope of the patent.
  • Patent Scope Metrics: Independent claim length and count are useful metrics for assessing the breadth and clarity of patent claims.
  • Examination Process: The patent examination process often narrows the scope of claims, enhancing clarity and reducing potential disputes.
  • Infringement Analysis: Infringement claims involve two steps: claim construction and comparison with the accused product.
  • Trade Secrets: Protecting trade secrets is vital in maintaining competitive advantage, especially in cases involving patent disputes.

FAQs

Q: What is the significance of claim construction in patent law? A: Claim construction is essential as it determines the scope of what is protected by the patent, helping to resolve disputes over infringement.

Q: How can the scope of a patent be measured? A: The scope can be measured using metrics such as independent claim length and independent claim count, which help in assessing the breadth and clarity of the claims.

Q: What is the role of the USPTO in patent searches? A: The USPTO provides various tools like the Patent Public Search, Global Dossier, and PTRCs to facilitate comprehensive patent searches and analysis.

Q: Why is protecting trade secrets important in patent disputes? A: Protecting trade secrets is crucial as it helps in maintaining competitive advantage and preventing unauthorized use of confidential information.

Q: How does the patent examination process affect the scope of patent claims? A: The examination process tends to narrow the scope of claims, making them clearer and reducing the likelihood of disputes.

Sources

  1. Baxter Healthcare Corp. v. HQ Specialty Pharma Corp., 133 F. Supp. 3d 1321.
  2. DECHERT LLP UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY.
  3. Patent Claims and Patent Scope, SSRN.
  4. USPTO - Search for patents.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,310,094

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.